Globus Medical Inc. (GMED)
NYSE · Healthcare
Globus Medical Inc. EBITDA 2010–2025
Globus Medical Inc. annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Globus Medical Inc. ebitda for the quarter ending March 31, 2026 was 220.2 M, a 35.40% increase year-over-year.
- Globus Medical Inc. ebitda for the twelve months ending March 31, 2026 was 520.7 M, a 129.03% increase year-over-year.
- Globus Medical Inc. annual ebitda for 2025 was 756.7 M, a 80.42% increase from 2024.
- Globus Medical Inc. annual ebitda for 2024 was 419.4 M, a 50.49% increase from 2023.
- Globus Medical Inc. annual ebitda for 2023 was 278.7 M, a 5.92% decrease from 2022.
- Globus Medical Inc. annual ebitda for 2022 was 296.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Globus Medical Inc. EBITDA — FAQ
Globus Medical Inc. (GMED) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GMED's ebitda history?
The chart and table above show Globus Medical Inc.'s ebitda by year and by quarter, including the growth rate.